4.6 Review

Pathophysiology of lipid droplet proteins in liver diseases

期刊

EXPERIMENTAL CELL RESEARCH
卷 340, 期 2, 页码 187-192

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2015.10.021

关键词

Liver; Lipids; Lipid droplet; Perilipin; Steatosis; Hepatitis; Obesity; Diabetes; Alcohol; NAFLD; HCV

资金

  1. National Institutes of Health [K08-AA021424, P01-DK049210]
  2. Penn Diabetes Research Center [P30-DK-50306]
  3. Robert Wood Johnson Foundation, Harold Amos Medical Faculty Development Award [71586]

向作者/读者索取更多资源

Cytosolic lipid droplets (LDs) are present in most cell types, and consist of a core comprising neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of phospholipids. LDs are heterogeneous in their structure, chemical composition, and tissue distribution. LDs are coated by several proteins, including perilipins and other structural proteins, lipogenic enzymes, lipases and membrane trafficking proteins. Five proteins of the perilipin (PLIN) family (PLIN1 (perilipin), PLIN2 (adipose differentiation-related protein), PLIN3 (tail-interacting protein of 47 kDa), PLIN4 (S3-12), and PLIN5 (myocardial lipid droplet protein)), are associated with LD formation. More recently, the CIDE family of proteins, hypoxia-inducible protein 2 (HIG2), and patanin-like phospholipase domain-containing 3 (PNPLA3) have also gained attention in hepatic LD biology. Evidence suggests that LD proteins are involved in the pathophysiology of fatty liver diseases characterized by excessive lipid accumulation in hepatocytes. This review article will focus on how hepatic LDs and their associated proteins are involved in the pathogenesis of three chronic liver conditions: hepatitis C virus infection, non-alcoholic fatty liver disease, and alcoholic liver disease. (C) 2015 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据